Skip to main content
21+Industry intelligence — not direct nicotine sales
Regulation & Policy

FDA Seeks Public Input to Support Ibogaine Research

Summary: The U.S. Food and Drug Administration today announced a request for information (RFI) describing approaches the agency is considering for the design of early-phase clinical trials of ibogaine drug products and seeking…

The U.S. Food and Drug Administration today announced a request for information (RFI) describing approaches the agency is considering for the design of early-phase clinical trials of ibogaine drug products and seeking public input on those approaches.

Adults 21+. WINDBAR does not sell nicotine products on this site. Compliance statement.

← Back to Regulation & Policy